Mandate

Vinge has advised Fortinova Fastigheter in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Fortinova Fastigheter AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm. The prospectus was published on 12 November 2025 and the trading on Nasdaq Stockholm commenced on 19 November 2025, five years to the day since the first listing.

Fortinova is an expansive real estate company based in Varberg whose business concept, since its inception in 2010, has consisted of acquiring, developing, and managing primarily residential properties with documented positive cash flows. The group aims to generate positive returns over time, regardless of market developments. Fortinova has a geographical focus on growth municipalities in western Sweden that are deemed to have a strong growth profile and are attractive places to live, work, and reside in. The Company’s property portfolio has a total property value amounting to approximately SEK 5.1 billion.

Vinge’s team consisted of Anders Strid, Wibeke Sorling, Edin Agic, Amelia Rihs, Sofia Haggren, Marcus Bergström and Oliwer Vidarsson (Capital Markets and Public M&A), Adam Loewenstein (Real Estate), Michaela Örtberg (IPR) and Amanda Stoltz (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026